HRS-1167 is under clinical development by Merck and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC).

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Conservative MP Luc Berthold has announced he has prostate cancer. The longtime member of Parliament for Quebec’s ...

It is true that excess sodium has health risks, and I agree with public health officials in recommending that people consume ...

By Judith Graham KFF Health News Bill Hall, 71, has been fighting for his life for 38 years. These days, he’s feeling worn ...

Despite medical advances and increased awareness campaigns, many men continue postponing essential prostate treatment. Health care providers identify ...

US Surgeon General Dr. Vivek Murthy issued an advisory Friday warning Americans that alcohol consumption can increase their ...

The AP reported that Netanyahu is expected to remain in the hospital for several days. According to Johns Hopkins Medicine, it is recommended not to perform strenuous activity or heavy lifting for at ...

After skin cancer, prostate cancer is the most common cancer in men in the US. For the men who have beat prostate cancer once, 20 to 30 percent will show signs of recurrence after the five-year mark ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current stand ...